ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680931; 2) Community: the network communities that were significantly associated with the response to NSC 680931; 3) Molecule: the relationships between components within communities and NSC 680931; 4) MDR: the compounds that were significantly associated with the NSC 680931.

NSC Compound Enrichment Correlation
NSC 754664 3-amino-N-(5-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide 0.0260391472224207 0.26356865
NSC 761130 (E)-6-chloro-3-((2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl)methylene)indolin-2-one 0.0260391472224207 0.50651151
NSC 113423 NSC 113423 0.0267520285931239 0.30137143
NSC 120925 Null 0.0267520285931239 0.40831316
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0267520285931239 0.18224715
NSC 13484 Null 0.0267520285931239 0.2220343
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0267520285931239 0.47707505
NSC 330507 Tanespimycin 0.0267520285931239 0.32110287
NSC 346098 Null 0.0267520285931239 0.31008902
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0267520285931239 0.3243412
Total:114  Current:67    [First] [Prev] [Next] [Last]